BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1899498)

  • 1. Contrast enhancement of the labyrinth on MR scans in patients with sudden hearing loss and vertigo: evidence of labyrinthine disease.
    Seltzer S; Mark AS
    AJNR Am J Neuroradiol; 1991; 12(1):13-6. PubMed ID: 1899498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Labyrinthine enhancement on gadolinium-enhanced magnetic resonance imaging in sudden deafness and vertigo: correlation with audiologic and electronystagmographic studies.
    Mark AS; Seltzer S; Nelson-Drake J; Chapman JC; Fitzgerald DC; Gulya AJ
    Ann Otol Rhinol Laryngol; 1992 Jun; 101(6):459-64. PubMed ID: 1610062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of Gd-DTPA-enhanced MR imaging of the labyrinth in patients with sudden hearing loss.
    Papadopoulos A; Vlahos L; Xenelis J; Papafragou C; Adamopoulos G
    Magn Reson Imaging; 1995; 13(3):387-91. PubMed ID: 7791548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathology of the membranous labyrinth: comparison of T1- and T2-weighted and gadolinium-enhanced spin-echo and 3DFT-CISS imaging.
    Casselman JW; Kuhweide R; Ampe W; Meeus L; Steyaert L
    AJNR Am J Neuroradiol; 1993; 14(1):59-69. PubMed ID: 8427112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance examination of the inner ear and cerebellopontine angle in patients with vertigo and/or abnormal findings at vestibular testing.
    Casselman JW; Kuhweide R; Dehaene I; Ampe W; Devlies F
    Acta Otolaryngol Suppl; 1994; 513():15-27. PubMed ID: 8191885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensorineural hearing loss: more than meets the eye?
    Mark AS; Seltzer S; Harnsberger HR
    AJNR Am J Neuroradiol; 1993; 14(1):37-45. PubMed ID: 8427110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI of inner ear and facial nerve pathology using 3D MP-RAGE and 3D CISS sequences.
    Held P; Fellner C; Fellner F; Seitz J; Graf S; Hilbert M; Strutz J
    Br J Radiol; 1997 Jun; 70(834):558-66. PubMed ID: 9227246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in the blood-labyrinth barrier. Assessments by magnetic resonance].
    Manfrè L; Bencivinni F; Caronia A; Angileri T; Manasia G; De Maria M
    Radiol Med; 1999 Dec; 98(6):472-6. PubMed ID: 10755007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Controversial aspects of magnetic resonance imaging in sudden onset cochleovestibular diseases].
    Comacchio F; D'Eredità R; Marchiori C
    Acta Otorhinolaryngol Ital; 1997 Jun; 17(3):208-14. PubMed ID: 9489146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of fat-suppression technique and gadopentetate dimeglumine in magnetic resonance imaging evaluation of intraocular tumors and simulating lesions.
    De Potter P; Flanders AE; Shields JA; Shields CL; Gonzales CF; Rao VM
    Arch Ophthalmol; 1994 Mar; 112(3):340-8. PubMed ID: 8129659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing brain MR imaging protocols with gadopentetate dimeglumine: enhancement of intracranial lesions on spin-density- and T2-weighted images.
    Wessbecher FW; Maravilla KR; Dalley RW
    AJNR Am J Neuroradiol; 1991; 12(4):675-9. PubMed ID: 1882743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR imaging of the brain in patients with AIDS: value of routine use of i.v. gadopentetate dimeglumine.
    Jensen MC; Brant-Zawadzki M
    AJR Am J Roentgenol; 1993 Jan; 160(1):153-7. PubMed ID: 8416615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of gadopentetate dimeglumine for 1.5-T MR imaging of musculoskeletal masses: comparison with unenhanced T1- and T2-weighted imaging.
    Rosenthal RE; Wozney P
    J Magn Reson Imaging; 1991; 1(5):547-51. PubMed ID: 1790379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadolinium-enhanced T1-weighted versus T2-weighted imaging of scrotal disorders: is there an indication for MR imaging?
    Müller-Leisse C; Bohndorf K; Stargardt A; Sohn M; Neuerburg J; Adam G; Wein B; Urhahn R; Günther RW
    J Magn Reson Imaging; 1994; 4(3):389-95. PubMed ID: 8061438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rectal carcinoma: prospective comparison of conventional and gadopentetate dimeglumine enhanced fat-suppressed MR imaging.
    Okizuka H; Sugimura K; Yoshizako T; Kaji Y; Wada A
    J Magn Reson Imaging; 1996; 6(3):465-71. PubMed ID: 8724412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential diagnosis and prognosis of T1-weighted post-gadolinium intralabyrinthine hyperintensities.
    Dubrulle F; Kohler R; Vincent C; Puech P; Ernst O
    Eur Radiol; 2010 Nov; 20(11):2628-36. PubMed ID: 20862477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal MR protocol for hepatic hemangiomas. Comparison of conventional spin-echo sequences with T2-weighted turbo spin-echo and serial gradient-echo (FLASH) sequences with gadolinium enhancement.
    Kim TK; Choi BI; Han JK; Jang HJ; Han MC
    Acta Radiol; 1997 Jul; 38(4 Pt 1):565-71. PubMed ID: 9240679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detecting pulmonary abnormalities on magnetic resonance images in patients with usual interstitial pneumonitis: effect of varying window settings and gadopentetate dimeglumine.
    King MA; Bergin CJ; Ghadishah E; Yi ES; Clark JB
    Acad Radiol; 1996 Apr; 3(4):300-7. PubMed ID: 8796678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gadopentetate dimeglumine-enhanced MR imaging of the postoperative lumbar spine: comparison of fat-suppressed and conventional T1-weighted images.
    Mirowitz SA; Shady KL
    AJR Am J Roentgenol; 1992 Aug; 159(2):385-9. PubMed ID: 1632362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadopentetate dimeglumine-enhanced MR of the brain: clinical utility and safety in patients younger than two years of age.
    Eldevik OP; Brunberg JA
    AJNR Am J Neuroradiol; 1994 Jun; 15(6):1001-8. PubMed ID: 8073967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.